09:44 EDT Hims & Hers shares down 11% to $51.33 after Evernorth weight loss plan
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Cigna’s Evernorth caps monthly weight loss drug cost at $200
- Hims & Hers falls after Cigna offers cheaper obesity drug plan
- Hims & Hers growth moderated in April, says BofA
- Hims & Hers Health: Stabilizing Growth and Cautious Revenue Guidance Lead to Hold Rating
- Hims & Hers Health Issues $1 Billion in Notes